International Journal of Endocrinology and Metabolism

Published by: Kowsar

Genetic Identification for Non-Communicable Disease: Findings from 20 Years of the Tehran Lipid and Glucose Study

Maryam S Daneshpour 1 , Mehdi Hedayati 1 , Bahareh Sedaghati-Khayat 1 , Kamran Guity 1 , Maryam Zarkesh 1 , Mahdi Akbarzadeh 1 , Niloofar Javanrooh 1 , Azita Zadeh-Vakili 1 and Fereidoun Azizi 2 , *
Authors Information
1 Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • International Journal of Endocrinology and Metabolism: October 2018, 16 (4 (Suppl)); e84744
  • Published Online: October 27, 2018
  • Article Type: Review Article
  • Received: September 1, 2018
  • Revised: October 2, 2018
  • Accepted: October 9, 2018
  • DOI: 10.5812/ijem.84744

To Cite: Daneshpour M S, Hedayati M, Sedaghati-Khayat B, Guity K , Zarkesh M , et al. Genetic Identification for Non-Communicable Disease: Findings from 20 Years of the Tehran Lipid and Glucose Study, Int J Endocrinol Metab. 2018 ; 16(4 (Suppl)):e84744. doi: 10.5812/ijem.84744.

Copyright © 2018, International Journal of Endocrinology and Metabolism. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
  • 1. Manolio TA, Bailey-Wilson JE, Collins FS. Genes, environment and the value of prospective cohort studies. Nat Rev Genet. 2006;7(10):812-20. doi: 10.1038/nrg1919. [PubMed: 16983377].
  • 2. Hunter DJ. Gene-environment interactions in human diseases. Nat Rev Genet. 2005;6(4):287-98. doi: 10.1038/nrg1578. [PubMed: 15803198].
  • 3. Polito L, Greco A, Seripa D. Genetic profile, environmental exposure, and their interaction in parkinson's disease. Parkinsons Dis. 2016;2016:6465793. doi: 10.1155/2016/6465793. [PubMed: 26942037]. [PubMed Central: PMC4752982].
  • 4. Azizi F, Madjid M, Rahmani M, Emami H, Mirmiran P, Hadjipour R. [Tehran lipid and glucose study (TLGS): Rationale and design]. Iran J Endocrinoland Metab. 2000;2(2):77-86. Persian.
  • 5. Daneshpour MS, Fallah MS, Sedaghati-Khayat B, Guity K, Khalili D, Hedayati M, et al. Rationale and design of a genetic study on cardiometabolic risk factors: Protocol for the Tehran Cardiometabolic Genetic Study (TCGS). JMIR Res Protoc. 2017;6(2). e28. doi: 10.2196/resprot.6050. [PubMed: 28232301]. [PubMed Central: PMC5344981].
  • 6. Faam B, Zarkesh M, Fallah MS, Hosseinzadeh N, Guity K, Hosseinpanah F. Heritability of obesity-related variables in Tehran families: Tehran lipid and glucose study. Scimetr. 2014;2(4). e18268. doi: 10.5812/scimetr.18268.
  • 7. Zarkesh M, Daneshpour MS, Faam B, Fallah MS, Hosseinzadeh N, Guity K, et al. Heritability of the metabolic syndrome and its components in the Tehran lipid and glucose study (TLGS). Genet Res (Camb). 2012;94(6):331-7. doi: 10.1017/S001667231200050X. [PubMed: 23374242].
  • 8. Azizi F, Farahani ZK, Ghanbarian A, Sheikholeslami F, Mirmiran P, Momenan AA, et al. Familial aggregation of the metabolic syndrome: Tehran lipid and glucose study. Ann Nutr Metab. 2009;54(3):189-96. doi: 10.1159/000217816. [PubMed: 19420912].
  • 9. Al-Chalabi A, Almasy L. Genetics of complex human diseases: a laboratory manual. Cold Spring Harbor Laboratory Press; 2009.
  • 10. Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study Phase II. Trials. 2009;10:5. doi: 10.1186/1745-6215-10-5. [PubMed: 19166627]. [PubMed Central: PMC2656492].
  • 11. Halalkhor S, Mesbah-Namin SA, Daneshpour MS, Hedayati M, Azizi F. Association of ATP-binding cassette transporter-A1 polymorphism with apolipoprotein AI level in Tehranian population. J Genet. 2011;90(1):129-32. doi: 10.1007/s12041-011-0030-9. [PubMed: 21677398].
  • 12. Bandarian F, Daneshpour MS, Hedayati M, Naseri M, Azizi F. Identification of sequence variation in the apolipoprotein A2 gene and their relationship with serum high-density lipoprotein cholesterol levels. Iran Biomed J. 2016;20(2):84-90. [PubMed: 26590203]. [PubMed Central: PMC4726888].
  • 13. Bandarian F, Hedayati M, Daneshpour MS, Naseri M, Azizi F. Genetic polymorphisms in the APOA1 gene and their relationship with serum HDL cholesterol levels. Lipids. 2013;48(12):1207-16. doi: 10.1007/s11745-013-3847-6. [PubMed: 24081495].
  • 14. Daneshpour MS, Faam B, Hedayati M, Eshraghi P, Azizi F. ApoB (XbaI) polymorphism and lipid variation in Teharnian population. Eur J Lipid Sci Technol. 2011;113(4):436-40. doi: 10.1002/ejlt.201000346.
  • 15. Daneshpour MS, Faam B, Mansournia MA, Hedayati M, Halalkhor S, Mesbah-Namin SA, et al. Haplotype analysis of Apo AI-CIII-AIV gene cluster and lipids level: Tehran lipid and glucose study. Endocrine. 2012;41(1):103-10. doi: 10.1007/s12020-011-9526-6. [PubMed: 22105741].
  • 16. Daneshpour MS, Zarkesh M, Hedayati M, Mesbah SMN, Halalkhor S, Faam B, et al. The G360t polymorphism in the APO AIV gene and its association with combined HDL/LDL cholesterol phenotype: Tehran lipid and glucose study. Int JEndocrinol Metab. 2010;2010(1):32-8.
  • 17. Daneshpour MS, Hedayati M, Eshraghi P, Azizi F. Association of Apo E gene polymorphism with HDL level in Tehranian population. Eur J Lipid Sci Technol. 2010;112(7):810-6. doi: 10.1002/ejlt.200900207.
  • 18. Faam B, Daneshpour MS, Hedayati M, Halalkhor S, Mansournia MA, Zarkesh M, et al. The age effect on the association between the scavenger receptor class B type I (SR-BI) polymorphism and HDL-C level: Tehran lipid and glucose study. Endocr Res. 2014;39(3):91-3. doi: 10.3109/07435800.2013.808207. [PubMed: 24738490].
  • 19. Barkowski RS, Frishman WH. HDL metabolism and CETP inhibition. Cardiol Rev. 2008;16(3):154-62. doi: 10.1097/CRD.0b013e31816a3b60. [PubMed: 18414186].
  • 20. Daneshpour MS, Hedayati M, Azizi F. TaqI B1/B2 and -629A/C cholesteryl ester transfer protein (CETP) gene polymorphisms and their association with CETP activity and high-density lipoprotein cholesterol levels in a Tehranian population. Part of the Tehran lipid and glucose study (TLGS). Genet Mol Biol. 2007;30(4):1039-46. doi: 10.1590/s1415-47572007000600001.
  • 21. Kashani Farid MA, Azizi F, Hedayati M, Daneshpour MS, Shamshiri AR, Siassi F. Association between CETP Taq1B and LIPC -514C/T polymorphisms with the serum lipid levels in a group of Tehran's population: A cross sectional study. Lipids Health Dis. 2010;9:96. doi: 10.1186/1476-511X-9-96. [PubMed: 20822508]. [PubMed Central: PMC2944238].
  • 22. Daneshpour M, Faam B, Hedayati M, Azizi F. [Presence of the X+ allele in apolipoprotein B gene increase the total cholesterol and apolipoprotein B concentration in Tehranian people]. Iran J Endocrinol Metab. 2011;12(6):588-93. Persian.
  • 23. Gretarsdottir S, Helgason H, Helgadottir A, Sigurdsson A, Thorleifsson G, Magnusdottir A, et al. A splice region variant in LDLR lowers non-high density lipoprotein cholesterol and protects against coronary artery disease. PLoS Genet. 2015;11(9). e1005379. doi: 10.1371/journal.pgen.1005379. [PubMed: 26327206]. [PubMed Central: PMC4556698].
  • 24. Boes E, Coassin S, Kollerits B, Heid IM, Kronenberg F. Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: A systematic in-depth review. Exp Gerontol. 2009;44(3):136-60. doi: 10.1016/j.exger.2008.11.003. [PubMed: 19041386]. [PubMed Central: PMC2730542].
  • 25. Naseri M, Hedayati M, Daneshpour MS, Bandarian F, Azizi F. Identification of genetic variants of lecithin cholesterol acyltransferase in individuals with high HDLC levels. Mol Med Rep. 2014;10(1):496-502. doi: 10.3892/mmr.2014.2177. [PubMed: 24789697].
  • 26. Naseri M, Hedayati M, Daneshpour MS, Bandarian F, Azizi F. A comparison of lecithin cholesterol acyltransferase gene variation among individuals with high and low HDL levels in Tehran lipid and glucose study (TLGS). Iran J Endocrinol Metab. 2015;17(3):206-14.
  • 27. National Cholesterol Education Program Expert Panel on Detection Evaluation; Treatment of High Blood Cholesterol in Adults. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106(25):3143-421. doi: 10.1161/circ.106.25.3143. [PubMed: 12485966].
  • 28. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469-80. doi: 10.1111/j.1464-5491.2006.01858.x. [PubMed: 16681555].
  • 29. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5. doi: 10.1161/CIRCULATIONAHA.109.192644. [PubMed: 19805654].
  • 30. Azizi F, Khalili D, Aghajani H, Esteghamati A, Hosseinpanah F, Delavari A, et al. Appropriate waist circumference cut-off points among Iranian adults: The first report of the Iranian National Committee of Obesity. Arch Iran Med. 2010;13(3):243-4. [PubMed: 20433230].
  • 31. Hosseini-Esfahani F, Daneshpour MS, Mirmiran P, Mehrabi Y, Hedayati M, Azizi F. Interaction of APOC3 polymorphism and dietary fats on the risk of metabolic syndrome. Iran J Endocrinol Metabo. 2015;16(5):345-55.
  • 32. Hosseini-Esfahani F, Mirmiran P, Daneshpour MS, Mottaghi A, Azizi F. The effect of interactions of single nucleotide polymorphisms of APOA1/APOC3 with food group intakes on the risk of metabolic syndrome. Avicenna J Med Biotechnol. 2017;9(2):94-103. [PubMed: 28496949]. [PubMed Central: PMC5410135].
  • 33. Fallah MS, Sedaghatikhayat B, Guity K, Akbari F, Azizi F, Daneshpour MS. The relation between metabolic syndrome risk factors and genetic variations of apolipoprotein v in relation with serum triglyceride and HDL-C level. Arch Iran Med. 2016;19(1):46-50. [PubMed: 26702748].
  • 34. Zadeh-Vakili A, Faam B, Daneshpour MS, Hedayati M, Azizi F. Association of CD36 gene variants and metabolic syndrome in Iranians. Genet Test Mol Biomarkers. 2012;16(4):234-8. doi: 10.1089/gtmb.2011.0195. [PubMed: 22047506]. [PubMed Central: PMC3326263].
  • 35. Javanrouh N, Daneshpour MS, Soltanian AR, Tapak L. Kernel machine SNP set analysis provides new insight into the association between obesity and polymorphisms located on the chromosomal 16q.12.2 region: Tehran lipid and glucose study. Gene. 2018;658:146-51. doi: 10.1016/j.gene.2018.03.006. [PubMed: 29524577].
  • 36. Sedaghati-Khayat B, Barzin M, Akbarzadeh M, Guity K, Fallah MS, Pourhassan H, et al. Lack of association between FTO gene variations and metabolic healthy obese (MHO) phenotype: Tehran Cardio-metabolic Genetic Study (TCGS). Eat Weight Disord. 2018. doi: 10.1007/s40519-018-0493-2. [PubMed: 29525920].
  • 37. Pilia G, Chen WM, Scuteri A, Orru M, Albai G, Dei M, et al. Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet. 2006;2(8). e132. doi: 10.1371/journal.pgen.0020132. [PubMed: 16934002]. [PubMed Central: PMC1557782].
  • 38. Eshraghi P, Hedayati M, Daneshpour MS, Mirmiran P, Azizi F. Association of body mass index and Trp64Arg polymorphism of the beta3-adrenoreceptor gene and leptin level in Tehran lipid and glucose study. Br J Biomed Sci. 2007;64(3):117-20. doi: 10.1080/09674845.2007.11732769. [PubMed: 17910280].
  • 39. Lalami ZA, Ebrahimi A, Daneshpour MS. [Evaluating the relation of rs1801282 polymorphism in PPAR-γ gene with obesity in Tehran lipid and glucose study (TLGS) participants]. Tehran Univ Med J. 2016;74(6):415-24. Persian.
  • 40. Hedayati M, Sharifi K, Rostami F, Daneshpour MS, Zarif Yeganeh M, Azizi F. Association between TNF-alpha promoter G-308A and G-238A polymorphisms and obesity. Mol Biol Rep. 2012;39(2):825-9. doi: 10.1007/s11033-011-0804-4. [PubMed: 21559831]. [PubMed Central: PMC3249554].
  • 41. Georgia S, Bhushan A. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest. 2004;114(7):963-8. doi: 10.1172/JCI22098. [PubMed: 15467835]. [PubMed Central: PMC518666].
  • 42. Steinthorsdottir V, Thorleifsson G, Sulem P, Helgason H, Grarup N, Sigurdsson A, et al. Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes. Nat Genet. 2014;46(3):294-8. doi: 10.1038/ng.2882. [PubMed: 24464100].
  • 43. American Diabetes A. Standards of medical care in diabetes--2013. Diabetes Care. 2013;36 Suppl 1:S11-66. doi: 10.2337/dc13-S011. [PubMed: 23264422]. [PubMed Central: PMC3537269].
  • 44. Taurog A, Dorris M, Doerge DR. Evidence for a radical mechanism in peroxidase-catalyzed coupling. I. Steady-state experiments with various peroxidases. Arch Biochem Biophys. 1994;315(1):82-9. doi: 10.1006/abbi.1994.1474. [PubMed: 7979410].
  • 45. Jaume JC, Burek CL, Hoffman WH, Rose NR, McLachlan SM, Rapoport B. Thyroid peroxidase autoantibody epitopic 'fingerprints' in juvenile Hashimoto's thyroiditis: Evidence for conservation over time and in families. Clin Exp Immunol. 1996;104(1):115-23. doi: 10.1046/j.1365-2249.1996.d01-659.x. [PubMed: 8603516]. [PubMed Central: PMC2200393].
  • 46. Bakker B, Bikker H, Vulsma T, de Randamie JS, Wiedijk BM, De Vijlder JJ. Two decades of screening for congenital hypothyroidism in The Netherlands: TPO gene mutations in total iodide organification defects (an update). J Clin Endocrinol Metab. 2000;85(10):3708-12. doi: 10.1210/jcem.85.10.6878. [PubMed: 11061528].
  • 47. Fugazzola L, Mannavola D, Vigone MC, Cirello V, Weber G, Beck-Peccoz P, et al. Total iodide organification defect: Clinical and molecular characterization of an Italian family. Thyroid. 2005;15(9):1085-8. doi: 10.1089/thy.2005.15.1085. [PubMed: 16187919].
  • 48. Hedayati M, Salehi Jahromi M, Zarif Yeganeh M, Daneshpour MS, Hoghooghi Rad L, Azizi F. Association between serum level of anti-TPO titer and polymorphisms G1193/C Exon 8 and C2145/T Exon 12 of thyroid peroxidase gene in an Iranian population. Int J Endocrinol Metab. 2010;8(2):64-7.
  • 49. Faam B, Daneshpour MS, Azizi F, Hedayati M. Association of T2229/C Exon 12 polymorphisms of thyroid peroxidase gene with anti-TPO levels in Tehran population. J Zanjan Univ Med Sci. 2011;19(74):37-43.
  • 50. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85(7):2434-8. doi: 10.1210/jcem.85.7.6682. [PubMed: 10902790].
  • 51. Mehrabian F, Khani B, Kelishadi R, Ghanbari E. The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynol Pol. 2011;62(3):238-42. [PubMed: 21717406].
  • 52. Ramezani Tehrani F, Daneshpour M, Hashemi S, Zarkesh M, Azizi F. Relationship between polymorphism of insulin receptor gene, and adiponectin gene with PCOS. Iran J Reprod Med. 2013;11(3):185-94. [PubMed: 24639745]. [PubMed Central: PMC3943219].
  • 53. Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, Roesler S, et al. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2006;114(10):577-83. doi: 10.1055/s-2006-948308. [PubMed: 17177140].
  • 54. Wehr E, Pilz S, Schweighofer N, Giuliani A, Kopera D, Pieber TR, et al. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol. 2009;161(4):575-82. doi: 10.1530/EJE-09-0432. [PubMed: 19628650].
  • 55. Yildizhan R, Kurdoglu M, Adali E, Kolusari A, Yildizhan B, Sahin HG, et al. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet. 2009;280(4):559-63. doi: 10.1007/s00404-009-0958-7. [PubMed: 19214546].
  • 56. Styrkarsdottir U, Helgason H, Sigurdsson A, Norddahl GL, Agustsdottir AB, Reynard LN, et al. Whole-genome sequencing identifies rare genotypes in COMP and CHADL associated with high risk of hip osteoarthritis. Nat Genet. 2017;49(5):801-5. doi: 10.1038/ng.3816. [PubMed: 28319091].
  • 57. Hosseini-Esfahani F, Mirmiran P, Daneshpour MS, Mehrabi Y, Hedayati M, Soheilian-Khorzoghi M, et al. Dietary patterns interact with APOA1/APOC3 polymorphisms to alter the risk of the metabolic syndrome: The Tehran lipid and glucose study. Br J Nutr. 2015;113(4):644-53. doi: 10.1017/S0007114514003687. [PubMed: 25653052].
  • 58. Zarkesh M, Daneshpour MS, Hedayati M, Azizi F. [Association of apolipoprotein A-IV gene G360T polymorphism with metabolic syndrome: Tehran lipid and glucose study]. Iran J Endocrinol Metab. 2012;14(1):10-7. Persian.
  • 59. Zarkesh M, Daneshpour MS, Faam B, Hedayati M, Azizi F. Is there any association of apolipoprotein E gene polymorphism with obesity status and lipid profiles? Tehran lipid and glucose study (TLGS). Gene. 2012;509(2):282-5. doi: 10.1016/j.gene.2012.07.048. [PubMed: 22921891].
  • 60. Zadeh Vakili A, Faam B, Daneshpour MS, Hedayati M, Azizi F. [Association of rs10499859 A> G and rs13246513 C> T variants of CD36 gene and metabolic syndrome: TLGS]. Iran J Endocrinol Metab. 2013;15(1):86-93. Persian.
  • 61. Moslehizadeh V, Ajamian F, Ebrahimi A, Delshad Siahkali H. [Association of FABP2 gene polymorphism (rs1799883) with risk of obesity in the Tehran lipid and glucose study (TLGS) population]. Tehran Univ Med J. 2016;73(12):864-71. Persian.
  • 62. Hosseini-Esfahani F, Koochakpoor G, Daneshpour MS, Sedaghati-Khayat B, Mirmiran P, Azizi F. Mediterranean dietary pattern adherence modify the association between FTO genetic variations and obesity phenotypes. Nutrients. 2017;9(10). doi: 10.3390/nu9101064. [PubMed: 28954439]. [PubMed Central: PMC5691681].
  • 63. Rostami F, Hosseini H, Sharifi K, Daneshpour M, Azizi F, Hedayati M. Association of G-174C polymorphism of the interleukin-6 gene promoter with obesity in Iranian population. World Acad Sci Eng Technol. 2010;4(9):400-3.
  • 64. Naseri M, Hedayati M, Daneshpour MS, Bandarian F, Azizi F. Association of lecithin cholesterol acyltransferase rs5923 polymorphism in Iranian individuals with extremely low high-density lipoprotein cholesterol: Tehran lipid and glucose study. Iran Biomed J. 2015;19(3):172-6. [PubMed: 26117245]. [PubMed Central: PMC4571013].
  • 65. Daneshpour MS, Hedayati M, Azizi F. Hepatic lipase C-514T polymorphism and its association with high-density lipoprotein cholesterol level in Tehran. Eur J Cardiovasc Prev Rehabil. 2006;13(1):101-3. doi: 10.1097/01.hjr.0000183908.74989.0c. [PubMed: 16449872].
  • 66. Koochakpoor G, Daneshpour MS, Mirmiran P, Hosseini SA, Hosseini-Esfahani F, Sedaghatikhayat B, et al. The effect of interaction between Melanocortin-4 receptor polymorphism and dietary factors on the risk of metabolic syndrome. Nutr Metab (Lond). 2016;13:35. doi: 10.1186/s12986-016-0092-z. [PubMed: 27186233]. [PubMed Central: PMC4867980].
  • 67. Koochakpoor G, Hosseini-Esfahani F, Daneshpour MS, Hosseini SA, Mirmiran P. Effect of interactions of polymorphisms in the Melanocortin-4 receptor gene with dietary factors on the risk of obesity and type 2 diabetes: A systematic review. Diabet Med. 2016;33(8):1026-34. doi: 10.1111/dme.13052. [PubMed: 26666384].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments